Trial Profile
Vaccine Biotherapy of Cancer: Tumor Cells and Dendritic Cells as Active Specific Immunotherapy of Patients With Metastatic Melanoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 28 Jul 2016
Price :
$35
*
At a glance
- Drugs Eltrapuldencel-T (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 27 Jul 2016 New trial record.